J. Herzog

发表

Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

W. Chung, P. Hall, V. Pankratz, 2013, PLoS genetics.

Abstract 3557: Reduced ovarian hormones & reduced mammographic & MRI determined breast density inBRCAcarriers following a hormonal chemo-prevention regimen of gonadotropin releasing hormone agonist (GnRHA) & low-dose add-back estrogen & testosterone:

M. Pike, G. Ursin, M. Press, 2012 .

Pharmacodynamic analyses in a multi-laboratory network: lessons from the poly(ADP-ribose) assay.

Yvonne A. Evrard, J. C. Schmitz, R. Parchment, 2016, Seminars in oncology.

Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico

C. Pérez-Plasencia, C. Villarreal-Garza, A. Mohar, 2015, Cancer.

Restriction endonuclease fingerprinting enhanced conformation sensitive gel electrophoresis (REF‐CSGE) in the analysis of BRCA1 exon 11 mutations in a high‐risk breast cancer cohort

J. Weitzel, G. Somlo, J. Herzog, 2002, Human mutation.

Prevalence of Hispanic BRCA1 and BRCA2 mutations among hereditary breast and ovarian cancer patients from Brazil reveals differences among Latin American populations.

P. Ashton-Prolla, J. Weitzel, J. Herzog, 2016, Cancer genetics.

Older breast cancer survivors may harbor hereditary cancer predisposition pathogenic variants and are at risk for clonal hematopoiesis.

T. Slavin, W. Dale, J. Weitzel, 2020, Journal of geriatric oncology.

Prevalence of BRCA Mutations and Founder Effect in High-Risk Hispanic Families

S. Neuhausen, R. Nelson, J. Weitzel, 2005, Cancer Epidemiology Biomarkers & Prevention.

Influence of Germline BRCA Genotype on the Survival of Patients with Triple-Negative Breast Cancer

S. Narod, P. Frankel, C. Villarreal-Garza, 2021, Cancer research communications.

Identiﬁcation of four novel susceptibility loci for oestrogen receptor negative breast cancer

Nussbaum, S. Cross, P. Fasching, 2016 .

Breast cancer associated pathogenic variants among women 61 years and older with triple negative breast cancer.

C. Hendricks, C. Villarreal-Garza, J. Weitzel, 2020, Journal of geriatric oncology.

Genetic, clinical and pathological characteristics of BRCA-associated breast cancer (BC) in Hispanic patients in the United States (US) and Latin America (LatAm).

C. Hendricks, P. Ganschow, J. Weitzel, 2017 .

Loss of five amino acids in BRCA2 is associated with ovarian cancer

J. Weitzel, J. Herzog, S. L. Martínez, 2004, Journal of Medical Genetics.

Evaluation of Lynch syndrome risk models in a multicenter diverse population.

G. Parmigiani, S. Gruber, G. Idos, 2022, Journal of Clinical Oncology.

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus

A. Whittemore, L. Kiemeney, S. Cross, 2016, Nature Communications.

Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.

E. John, S. Neuhausen, M. Beattie, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?

P. Ashton-Prolla, J. Coffa, J. Weitzel, 2017, PloS one.

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru

S. Narod, J. Weitzel, J. Herzog, 2015, Clinical genetics.

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

Jane E. Carpenter, A. Whittemore, W. Chung, 2016, Nature Communications.

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

Sandra L. Halverson, A. Whittemore, L. Kiemeney, 2016, Gynecologic oncology.

Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1- or BRCA2-Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083

A. Chen, D. Gandara, M. Goetz, 2017, Clinical Cancer Research.

Evidence for Common Ancestral Origin of a Recurring BRCA1 Genomic Rearrangement Identified in High-Risk Hispanic Families

G. Tomlinson, T. Scholl, J. Weitzel, 2007, Cancer Epidemiology Biomarkers & Prevention.

GENETIC TESTING FOR CANCER

A. Mohar, R. Álvarez, J. Weitzel, 2021 .

Genetic epidemiology of BRCA1- and BRCA2-associated cancer across Latin America

S. Neuhausen, P. Ashton-Prolla, C. Villarreal-Garza, 2021, npj Breast Cancer.

Spectrum of mismatch repair gene mutations and clinical presentation of Hispanic individuals with Lynch syndrome.

S. Gruber, J. Weitzel, Annette Y. Sunga, 2017, Cancer genetics.

The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes

S. Neuhausen, G. Petersen, T. Slavin, 2018, Familial Cancer.

Genetic epidemiology of BRCA1- and BRCA2-associated cancer across Latin America

S. Neuhausen, P. Ashton-Prolla, C. Villarreal-Garza, 2021, NPJ breast cancer.

Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

W. Chung, P. Hall, V. Pankratz, 2013, PLoS Genetics.

Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers

W. Chung, R. Nussbaum, D. Steinemann, 2015, PloS one.

DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Olufunmilayo I. Olopade, Mads Thomassen, Torben A. Kruse, 2014, PLoS genetics.

University of Groningen DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers Osorio,

Rensburg, A. Whittemore, D. Steinemann, 2014 .

Prospective Study of Cancer Genetic Variants: Variation in Rate of Reclassification by Ancestry

Julie O. Culver, T. Slavin, S. Gray, 2018, Journal of the National Cancer Institute.

Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.

J. Weitzel, S. Forman, J. Herzog, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Influence of Drug Absorption, Distribution, Metabolism, and Excretion (ADME) Variants on Sirolimus Blood Levels in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation

S. Forman, J. Herzog, D. Senitzer, 2013 .

The germline mutational landscape of BRCA1 and BRCA2 in Brazil

R. Reis, M. A. Moreira, H. Seuánez, 2018, Scientific Reports.

Genetic Gastric Cancer Susceptibility in the International Clinical Cancer Genomics Community Research Network.

Yate-Ching Yuan, S. Neuhausen, T. Slavin, 2017, Cancer genetics.

The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer

S. Narod, C. Villarreal-Garza, A. Mohar, 2015, Breast Cancer Research and Treatment.

Germline DNA Repair Genes Pathogenic Variants Among Mexican Patients With Prostate Cancer.

J. Weitzel, J. Herzog, D. Castillo, 2023, Clinical genitourinary cancer.

Development and Pilot Implementation of the Genomic Risk Assessment for Cancer Implementation and Sustainment (GRACIAS) Intervention in Mexico

A. Mohar, R. Álvarez, J. Weitzel, 2021, JCO global oncology.

The germline mutational landscape of BRCA1 and BRCA2 in Brazil

R. Reis, M. A. Moreira, H. Seuánez, 2018, Scientific Reports.

Correction: BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?

P. Ashton-Prolla, J. Coffa, J. Weitzel, 2018, PloS one.

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

Sandra L. Halverson, A. Whittemore, L. Kiemeney, 2016, Gynecologic oncology.